Integrative Transcriptome-Wide Association Study and Mendelian Randomization Identify LYNX1 and MS4A14 as Therapeutic...

Area of Science:

• Genetics
• Immunology
• Computational Biology

Background:

• Osteomyelitis is a severe bone infection often caused by Staphylococcus aureus.
• Antibiotic resistance and biofilm formation complicate treatment, necessitating novel therapeutic targets.
• Understanding the genetic basis of osteomyelitis is crucial for developing effective therapies.

Purpose of the Study:

• To systematically identify causal genes associated with osteomyelitis susceptibility using an integrative computational approach.
• To explore the potential of LYNX1 and MS4A14 as therapeutic targets for osteomyelitis.
• To bridge genome-wide association study findings with biological interpretation for precision medicine.

Main Methods:

• Transcriptome-wide association study (TWAS) combined with summary-based Mendelian randomization (SMR) analysis.
• Utilized large-scale genetic variants as instrumental variables to predict gene expression across tissues.
• Investigated causal associations between gene expression and osteomyelitis risk.

Main Results:

• Identified LYNX1 as a gene associated with increased susceptibility to osteomyelitis.
• Identified MS4A14 as a gene with potential protective properties against osteomyelitis.
• Highlighted the regulatory roles of LYNX1 and MS4A14 in immune response and inflammation during bone infection.

Conclusions:

• LYNX1 and MS4A14 are key candidate genes for osteomyelitis, offering potential therapeutic targets.
• Findings advance the understanding of osteomyelitis' genetic underpinnings.
• Supports the development of precision medicine strategies to enhance host defense and combat therapeutic resistance in osteomyelitis.